Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) EBT Margin (2019 - 2025)

Historic EBT Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 14.35%.

  • Legend Biotech's EBT Margin rose 611100.0% to 14.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 25.21% for FY2024, which is 250300.0% down from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's EBT Margin is 14.35%, which was up 611100.0% from 48.93% recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's EBT Margin ranged from a high of 63.61% in Q1 2024 and a low of 1612.82% during Q2 2022
  • Moreover, its 5-year median value for EBT Margin was 65.09% (2023), whereas its average is 289.19%.
  • Per our database at Business Quant, Legend Biotech's EBT Margin tumbled by -11601800bps in 2022 and then soared by 13416700bps in 2023.
  • Quarter analysis of 5 years shows Legend Biotech's EBT Margin stood at 1044.23% in 2021, then soared by 53bps to 491.16% in 2022, then surged by 100bps to 0.0% in 2023, then surged by 11856bps to 0.02% in 2024, then tumbled by -66160bps to 14.35% in 2025.
  • Its EBT Margin was 14.35% in Q3 2025, compared to 48.93% in Q2 2025 and 50.82% in Q1 2025.